5/16/2006 1:17:16 PM ET


    SWISS MEDICA LAUNCHES PMS ESCAPE® TELEVISION CAMPAIGN
      
    FOR IMMEDIATE RELEASE

    Stock Symbol: OTC BB: SWME
    May 16, 2006

    SWISS MEDICA LAUNCHES PMS ESCAPE® TELEVISION CAMPAIGN

    Toronto, Canada – Swiss Medica, Inc. (OTC BB: SWME) to announce that it is launching a television campaign
    for its PMS Escape® product in the Midwest USA beginning this week. The 30 second television spot will air in
    Columbus, Ohio, Indianapolis, Indiana and Detroit Michigan from May 16 until June 10, 2006 and will highlight
    PMS Escape as a unique over-the-counter, patented, clinically tested and all natural product for the mood and
    appetite symptoms of premenstrual syndrome.

    Swiss Medica engaged Spot Runner, a new Internet-based advertising agency located in Los Angeles, Calif., to
    create the television spot and manage the campaign. Spot Runner specializes in making it fast, easy and
    affordable for businesses to advertise on TV.

    The commercial is intended to reach women between the ages of 25 and 45 suffering from the emotional and
    appetite problems of premenstrual syndrome. “We took a soft approach to reaching our target audience with our
    first-ever television spot,” explains Wendy Kramer, Vice President of Swiss Medica. “We wanted to let women
    know that we understand how delicate this subject matter is and how important it is to see women like themselves
    who can conquer the age old problems of PMS in a natural and healthy way,” Kramer continues. “We look
    forward to great success with our new campaign.”

    The spot, which highlights how PMS Escape® can help women get relief from the anger, irritability and tension of
    PMS, will be aired during The Today Show, Good Morning America, Ellen and Oprah in the Columbus market,
    while Indianapolis and Detroit will air the spot on stations such as HGTV, TNT and TBS. “By airing our spots
    during daytime television shows, we can reach women at a time when they will really listen to what we have to
    say about PMS Escape®,” Kramer continues.

    PMS Escape® is available in the Feminine Hygiene section of CVS/Pharmacy and Meijers and online at
    Walgreens.com.

    About Swiss Medica, Inc.

    Swiss Medica commercializes proprietary bioscience products that relieve chronic ailments. We increase our
    market share through focused distribution strategies in multiple sales channels. Swiss Medica's mission is to be
    a world leader in the commercialization of life enhancing bioscience products that improve quality of lives. Please
    visit our websites at www.swissmedica.com, www.O24zone.com and www.pmsescape.com.

    Swiss Medica's flagship product, the O24™ Pain Neutralizer, holds US Patent #6,444,238B1. The O24™ pain
    relief solution has been used, recommended and praised for its fast-acting and long-lasting benefits by
    healthcare professionals and athletes in the United States, Canada and in Europe. O24™ is widely available
    throughout the United States and Canada in leading pharmacies and other retailers. Customers can also visit
    www.O24zone.com, for ordering details and store locators for the nearest pharmacy.

    Swiss Medica launched the patented O24 Fibromyalgia™ pain reliever (US Patent #6,444,238B1) over-the-
    counter in North American retailers in the fall of 2005. The National Fibromyalgia Association (NFA) recently
    awarded O24 Fibromyalgia™ their first NFA Seal of Approval. Upwards of 11 million Americans suffer from the
    long-term pain associated with fibromyalgia. In a randomized double blind clinical trial, more than 90 per cent of
    the patients who used O24 Fibromyalgia™ reported mild to markedly better improvement, versus only 7 per cent
    who used the placebo. Customers can visit www.O24zone.com for information on O24 Fibromyalgia™ and to
    order the product online.

    Swiss Medica also manufactures PMS Escape® which holds US Patent #'s 5760014 and 5612320. PMS
    Escape® is a specially formulated group of carbohydrates, vitamins and minerals, clinically proven to reduce
    changes in mood and appetite that women experience during the premenstrual period. Customers can also visit:
    www.pmsescape.com for additional information and ordering details.

    Forward-looking statements in this news release are made pursuant to the "Safe Harbor" provisions of the
    United States Private Securities Litigation Reform Act of 1995. Investors are cautioned that such forward-looking
    statements involve risks and uncertainties, including, without limitation, risks relating to the ability to close
    transactions being contemplated, risks related to international sales and potential foreign currency exchange
    fluctuations, continued acceptance of Swiss Medica's products, increased levels of competition, technological
    changes, dependence on intellectual property rights and other risks detailed from time to time in Swiss Medica's
    periodic reports filed with the United States Securities and Exchange Commission and other regulatory
    authorities.

    For more information, please contact:

    Swiss Medica, Inc.
    Investor Relations Contact:
    David Jones
    (866) 485-4243
    djones@swissmedica.com